July 29, 2009 – CircuLite Inc. said today it was awarded a Fast-Track Phase I-II Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) to fund the development of a pediatric circulatory assist device based upon CircuLite’s Synergy Pocket Micro-pump.
July 29, 2009 – Transoma Medical Inc., manufacturer of Sleuth AT wireless implantable cardiac monitoring system, today announced the first patient enrollment and implant in a long-term study to monitor patients who have been prescribed catheter ablation therapy for atrial fibrillation (AF) at risk of recurrence of AF after the procedure.
July 29, 2009 – The Society of Nuclear Medicine (SNM) and a coalition of eight other organizations have issued a white paper urging Congress to take steps to maintain adequate supplies of molybdenum-99 (Mo-99), a radioactive substance that is the basis for a common medical isotope used in more than 80 percent of all nuclear medicine procedures.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
July 28, 2009 – Bioheart Inc. today said the FDA cleared a phase I clinical trial for MyoCell SDF-1 (Stromal Derived Factor - 1) to treat congestive heart failure.
July 28, 2009 – Sanofi-aventis said today MULTAQ (dronedarone) 400 mg tablets are now available in pharmacies in the United States.
July 28, 2009 – Onset Medical Corporation said today it received CE mark approval to begin marketing the SoloPath Endovascular Access Catheter in the European Union.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
July 28, 2009 – The American College of Cardiology (ACC) is taking a leading role in healthcare reform in partnership with patients, lawmakers and payers. The ACC said it is setting a new standard for healthcare delivery, one that centers on increasing the quality of care and ensuring greater patient access and value.
July 28, 2009 – Researchers may be able to predict future severe cardiac events in patients with known, stable coronary artery disease (CAD) using coronary calcium scoring, according to a study published today in the online edition of Radiology.
July 27, 2009 - TeraRecon Inc., a leader in advanced visualization and decision support solutions for medical imaging and a partner of the Society of Cardiovascular Computed Tomography (SCCT), and Agfa HealthCare released the first cardiac CT review and reporting solution which conforms to the SCCT’s published guidelines* for cardiac CT interpretation.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
July 27, 2009 – Prescient Medical Inc. received the prestigious 2009 North American Product Innovation of the Year Award from Frost & Sullivan for Atherosclerosis Lesion Management, for its efforts to reduce deaths related to heart attacks using the vProtect Luminal Shield.
July 27, 2009 – Terumo Cardiovascular Systems said Friday it initiated a phase II clinical trial for the Anaconda AAA (abdominal aortic aneurysm) stent graft system in the U.S.
July 27, 2009 – Carestream Health Inc. today launched a new Web-based cardiology PACS that offers a single integrated platform for diagnosis, image review and reporting for echocardiography, cardiac catheterization and nuclear cardiology procedures as well as electrocardiogram management.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
July 24, 2009 – Michael Jones has become the world’s first recipient of adult cardiac stem cells to treat congestive heart failure. Jones’ infusion on July 17 marks the world’s first phase-one, FDA-approved clinical trial using c-kit-positive cardiac stem cells to treat heart disease being conducted by a team of University of Louisville physicians at Jewish Hospital.
July 24, 2009 – Injured heart tissue normally can't regrow, but researchers at Children's Hospital Boston have now laid the groundwork for regenerating heart tissue after a heart attack without the use of stem cells, in patients with heart failure, or in children with congenital heart defects.
July 24, 2009 – The 30-day survival improved in patients with acute myocardial infarction complicated by cardiogenic shock who were treated with intra-aortic balloon pump (IABP) counterpulsation, according to a new study in the American Journal of Cardiology (vol. 104, issue 3, pages 327-332, August 2009).